Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ Post author:Sam Post published:January 21, 2018 Post category:BioPharma The deal has Sanofi paying $105 per share in cash. Source: BioSpace You Might Also Like Syndax To Announce First Quarter 2017 Financial Results And Host Conference Call And Webcast On May 8, 2017 April 30, 2017 Stemline Therapeutics Announces that Pivotal Trial of SL-401 in Blastic Plasmacytoid Dendritic Ce… October 30, 2017 KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly January 4, 2018
Syndax To Announce First Quarter 2017 Financial Results And Host Conference Call And Webcast On May 8, 2017 April 30, 2017
Stemline Therapeutics Announces that Pivotal Trial of SL-401 in Blastic Plasmacytoid Dendritic Ce… October 30, 2017
KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly January 4, 2018
